Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Day One Biopharmaceuticals (DAWN)

Annual Return

Over the past 3 years, DAWN has had an average annual return of +17.26%, underperforming the benchmark SPY, which returned +20.77% annual.

Over the past 5 years, DAWN has had an average annual return of +2.58%, underperforming the benchmark SPY, which returned +12.76% annual.

Since May 27, 2021, DAWN has had an average annual return of -3.69%, underperforming the benchmark SPY, which returned +12.84% annual.

202620252024202320222021
+131%-26.44%-13.21%-32.16%+27.72%-34.92%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+19.75%-5.03%+102.27%+0.42%+131%
2025-2.37%-26.77%-12.46%-1.89%-18.00%+1.91%+3.23%+11.92%-6.14%+5.55%+27.56%-1.80%-26.44%
2024+3.09%+11.16%-1.25%+3.51%-22.39%+3.84%+3.83%-3.27%+0.64%+5.69%-5.38%-9.03%-13.21%
2023+1.17%-15.39%-27.42%-7.26%+7.27%-10.22%+10.88%+1.90%-9.06%-3.59%-2.10%+26.07%-32.16%
2022-12.46%-7.39%-27.37%-14.12%-27.01%+187.84%-4.31%+37.14%-14.73%+5.53%+0.43%+1.37%+27.72%
2021-8.50%-3.88%+4.17%+17.32%-14.73%+2.99%-24.84%-8.27%-34.92%

Drawdown analysis of Day One Biopharmaceuticals (DAWN)

The maximum drawdown for the DAWN was -79.52%, occurring on May 27, 2022. This drawdown has not yet recovered.

The current DAWN drawdown is -22.89%.

Since May 27, 2021 DAWN has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 2 times
  • 10% or more: 3 times
DepthStartTo BottomBottomTo RecoverEndTotal
-79.52%Sep 1, 2021186May 27, 2022OngoingOngoingOngoing
-26.61%May 27, 20214Jun 3, 202145Aug 6, 202149
-17.60%Aug 6, 20213Aug 11, 20218Aug 23, 202111
-0.76%Aug 26, 20211Aug 27, 20212Aug 31, 20213